¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell fusion"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ÀºÄ£È¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
eukaryotic cell
ÁøÇÙ¼¼Æ÷
goblet cell
¼úÀܼ¼Æ÷
hair cell
Åм¼Æ÷
inflammatory cell
¿°Áõ¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
Kupffer's cell
º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mesenchymal cell
Áß°£¿±¼¼Æ÷
mesothelial cell
ÁßÇǼ¼Æ÷
mother cell
¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
neuroendocrine cell
½Å°æ³»ºÐºñ¼¼Æ÷
packed red blood cell
³óÃàÀûÇ÷±¸
parietal cell
º®¼¼Æ÷
perivascular cell
Ç÷°üÁÖÀ§¼¼Æ÷
plasma cell
ÇüÁú¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
basal cell adenoma
±âÀú¼¼Æ÷»ùÁ¾, ¹Ù´Ú¼¼Æ÷¾ÏÁ¾
basosqumaous cell acanthoma
±âÀúÆíÆò¼¼Æ÷°¡½Ã¼¼Æ÷Á¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
fusion of labia
À¶ÇÕÀ½¼ø;À½¼øÀ¯ÇÕ
fusion of thumb
¾öÁö¼Õ°¡¶ô»ÀÀ¶ÇÕÁõ
fusion-free position
À¶ÇÕÁ¦°Å¾ÈÀ§
fusion-frustrated position
À¶ÇÕÁ¦°Å¾ÈÀ§
glenoidal fusion
¾î±ú°üÀýÀ¶ÇÕÁõ
heat of fusion
À¶ÇÕ¿(ë×ùêæð).
radioulnar fusion
³ëÀÚ»ÀÀ¶ÇÕÁõ
range of fusion
À¶ÇÕ¹üÀ§
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
B cell
B¼¼Æ÷(~ á¬øà)
B cell
B ¼¼Æ÷
B cell
B ¼¼Æ÷.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
flicker fusion perimetry
ÇÁ¸¯Ä¿½Ã¾ßÃøÁ¤(¹ý)
flicker fusion test
ÇÁ¸¯Ä¿À¶ÇÕ°Ë»ç
fusion
À¶ÇÕ
fusion
À¶ÇÕ(ë×ùê)
fusion
À¶ÇÕÁõ
fusion activity
À¶ÇÕ´É
fusion angle
À¶ÇÕ°¢
fusion defect
À¶ÇÕ°áÇÔ
fusion defect (cleft palate)
À¶ÇÕ°áÇÔ (ÀÔõÀå°¥¸²Áõ)
fusion faculty
À¶ÇÕ·Â
fusion failure
À¶ÇÕºÎÀü
fusion of hallux
¾öÁö¹ß°¡¶ô»ÀÀ¶ÇÕÁõ
fusion of hip
¾ûµ¢°üÀýÀ¶ÇÕÁõ
fusion of knee
¹«¸°üÀýÀ¶ÇÕÁõ
fusion of labia
À¶ÇÕÀ½¼ø;À½¼øÀ¯ÇÕ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½